PHOX-2B

N/A

Report date: 2025/08/01 20:01:42

Base Information

Drug NamePHOX-2B
Drug Alias NamePHOX2B PC-CAR TPHOX-2B
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionPaired Like Homeobox 2B modulators
TargetsPaired Like Homeobox 2B
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMyrio Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlliance For Cancer Gene TherapyChildrens Hospital of Philadelphia
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A